| View |
|
BRP-115
|
Filgrastim
|
Topneuter
|
300mcg/mL
|
Solution for Injection (IV/SC)
|
-
|
Xiamen Amoytop Biotech Co., Ltd.
|
China
|
-
|
01 September 2022
|
24 August 2026
|
| View |
|
DRP-4426-01
|
Medroxyprogesterone Acetate
|
None
|
10mg
|
Tablet
|
-
|
Unicure Remedies Pvt. Ltd.
|
India
|
Automatic Renewal
|
01 September 2022
|
23 May 2028
|
| View |
|
DRP-3511
|
Fenofibrate
|
Zinof 200
|
200 mg
|
Capsule
|
Antihyperlipidemic
|
Sydenham Laboratories, Inc.
|
Philippines
|
-
|
27 December 2021
|
19 January 2027
|
| View |
|
HRP-441
|
Oral Rehydration Salts
|
Hydrite
|
Formulation Per liter (equivalent to 5 sachets in liter water): Sodium Potassium Chloride Citrate Glucose
75 mmol 20 mmol 68 mmol 10 mmol 75 mmol
Each sachet contains Sodium Chloride Trisodium Citrate Dehydrate Potassium Chloride Glucose, Anhydrous
520 mg 580 mg 300 mg 2.7 g
|
Granules for Solution (Unflavored)
|
Electrolyte Replenisher
|
Amherst Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
21 December 2021
|
24 January 2027
|
| View |
|
DR-XY40550
|
Cefuroxime (as axetil)
|
Furoxen
|
250 mg/5 mL
|
Granules for Suspension
|
Antibacterial (Cephalosporin)
|
Lloyd Laboratories, Inc
|
Philippines
|
-
|
21 December 2021
|
19 January 2027
|
| View |
|
HRP-230-03
|
Sodium Ascorbate
|
Tru - Cee
|
562.43mg
|
Capsule
|
Vitamin
|
San Marino Laboratories Corporation
|
Philippines
|
Automatic Renewal
|
20 December 2021
|
16 October 2026
|
| View |
|
DRP-4938-03
|
Tamsulosin hydrochloride
|
Unbranded
|
400 mcg
|
Enteric-Coated Tablet
|
Alpha-adrenoreceptor Antagonist
|
Unicure Remedies Pvt. Ltd
|
India
|
Renewal
|
08 December 2023
|
19 November 2028
|
| View |
|
DRP-9314-04
|
Rosuvastatin (as calcium)
|
ControLD 10
|
10 mg
|
Film-Coated Tablet
|
HMG-CoA Reductase Inhibitor
|
Umedica Laboratories Pvt. Ltd
|
India
|
-
|
17 December 2021
|
25 November 2025
|
| View |
|
DRP-9315-05
|
Rosuvastatin (as calcium)
|
ControLD 20
|
20 mg
|
Film-Coated Tablet
|
HMG-CoA Reductase Inhibitor
|
Umedica Laboratories Pvt. Ltd.
|
India
|
-
|
17 December 2021
|
25 November 2025
|
| View |
|
DR-XY39826
|
CEFOXITIN (as sodium) + Dextrose
|
None
|
1g/ 4%
|
Solution for Injection (IV Infusion)
|
Antibacterial
|
B. BRAUN MEDICAL INC.
|
USA
|
Automatic Renewal
|
16 December 2021
|
27 July 2026
|
| View |
|
DRP-4652-02
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Razocin
|
4 g/ 500 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial
|
Yeluri Formulations Pvt. Ltd.
|
India
|
-
|
14 December 2021
|
02 September 2025
|
| View |
|
DRP-6872-02
|
Meropenem (as trihydrate)
|
Multinem
|
1 g
|
Powder for Injection (IV)
|
Antibacterial (Carbapenem)
|
Sherrington Pharmaceuticals Pvt. Ltd.
|
India
|
-
|
13 December 2021
|
16 December 2025
|
| View |
|
DRP-9637-01
|
Piperacillin (as Sodium) + Tazobactam (as Sodium)
|
Retazollin-4.5
|
4 g/500 mg
|
Powder for IV Infusion
|
Antibacterial (Penicillin/Beta-Lactamase Inhibitor)
|
Injectcare Parenterals Pvt. Ltd
|
India
|
-
|
09 December 2021
|
23 April 2026
|
| View |
|
DRP-2899-15
|
Folic Acid
|
Sanoviz FA
|
5 mg
|
Tablet
|
Vitamin
|
Akums Drugs & Pharmaceuticals Ltd. (Plant I - Solid Oral Dosage Facility)
|
India
|
-
|
07 December 2021
|
05 April 2026
|
| View |
|
DRP-2985-08
|
Azithromycin (as Dihydrate)
|
Xithramed
|
500 mg
|
Tablet
|
Antibacterial
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
07 February 2024
|
16 June 2029
|
| View |
|
DRP-7377-02
|
Losartan Potassium + Hydrochlorothiazide
|
Hextan Plus
|
50 mg/12.5 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker/Diuretic
|
Hiral Labs Ltd.
|
India
|
-
|
07 December 2021
|
19 February 2026
|
| View |
|
DRP-9342-01
|
Methylprednisolone (as Sodium Succinate)
|
Trimesolone
|
500 mg
|
Powder for Injection (IM/IV)
|
Corticosteroid
|
Samarth Life Science Pvt. Ltd
|
India
|
-
|
07 December 2021
|
30 September 2026
|
| View |
|
DRP-9343-01
|
Methylprednisolone (as sodium succinate)
|
Trimesolone
|
1 g
|
Powder for Injection (I.M./I.V.)
|
Corticosteroid
|
Samarth Life Science Pvt. Ltd
|
India
|
Renewal
|
14 March 2022
|
03 April 2027
|
| View |
|
DRP-9638-01
|
Piperacillin (as Sodium) + Tazobactam (as Sodium)
|
Retazollin-2.25
|
2 g/250 mg
|
Powder for IV Infusion
|
Antibacterial (Penicillin/Beta-Lactamase Inhibitor)
|
Injectcare Parenterals Pvt. Ltd.
|
India
|
-
|
07 December 2021
|
23 April 2026
|
| View |
|
DRP-2370-03
|
Neomycin + Gramicidin + Nystatin + Triamcinolone Acetonide
|
Unbranded
|
2.5 mg/0.25 mg/100,000 units/1 mg per mL
|
Otic Solution
|
Antibacterial / Antifungal / Corticosteroid
|
Ashford Pharmaceutical Laboratories, Inc
|
Philippines
|
Renewal
|
12 October 2024
|
03 August 2030
|